Compare CNTY & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTY | ICCM |
|---|---|---|
| Founded | 1992 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.9M | 45.5M |
| IPO Year | 1993 | N/A |
| Metric | CNTY | ICCM |
|---|---|---|
| Price | $1.39 | $0.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $4.00 | $2.50 |
| AVG Volume (30 Days) | 124.8K | ★ 367.1K |
| Earning Date | 11-10-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $572,756,000.00 | $2,975,000.00 |
| Revenue This Year | $2.12 | $13.67 |
| Revenue Next Year | $7.22 | $38.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.30 | $0.59 |
| 52 Week High | $4.00 | $1.66 |
| Indicator | CNTY | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 38.91 | 43.62 |
| Support Level | $1.30 | $0.67 |
| Resistance Level | $1.53 | $0.72 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 38.60 | 69.49 |
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.